Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J. 2020;103(3):38–40.

Google Scholar 

Omer FAA, Hashim NM, Ibrahim MY, et al. Beta-mangostin demonstrates apoptogenesis in murine leukaemia (WEHI-3) cells in vitro and in vivo. BMC Complement Altern Med. 2017;17(1):366.

Article  PubMed  PubMed Central  Google Scholar 

Norouzi S, Norouzi M, Amini M, et al. Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways. Daru. 2016;24:1.

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Cao H, Xu Y, de Necochea-Campion R, et al. Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Exp Hematol. 2017;50:1–12.

Article  CAS  PubMed  Google Scholar 

DiNardo CD, Cortes JE. New treatment for acute myelogenous leukemia. Expert Opin Pharmacother. 2015;16(1):95–106.

Article  CAS  PubMed  Google Scholar 

Floren M, Gillette JM. Acute myeloid leukemia: therapy resistance and a potential role for tetraspanin membrane scaffolds. Int J Biochem Cell Biol. 2021;137: 106029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin. 1994;44(6):326–52.

Article  CAS  PubMed  Google Scholar 

Seth R, Singh A. Leukemias in Children. Indian J Pediatr. 2015;82(9):817–24.

Article  PubMed  Google Scholar 

Major CK, Kantarjian H, Sasaki K, et al. Survivorship in AML: a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years. Leuk Lymphoma. 2020;61(13):3120–7.

Article  PubMed  Google Scholar 

Kayser S, Levis MJ. Updates on targeted therapies for acute myeloid leukaemia. Br J Haematol. 2022;196(2):316–28.

Article  CAS  PubMed  Google Scholar 

Stubbins RJ, Francis A, Kuchenbauer F, et al. Management of Acute myeloid leukemia: a review for general practitioners in oncology. Curr Oncol. 2022;29(9):6245–59.

Article  PubMed  PubMed Central  Google Scholar 

Grimwade D, Ivey A, Huntly BJ. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127(1):29–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rose-Inman H, Kuehl D. Acute leukemia. Hematol Oncol Clin North Am. 2017;31(6):1011–28.

Article  PubMed  Google Scholar 

Ding HM, Chen XJ, Chen HM, et al. Effect of Sargassum fusiforme polysaccharide on apoptosis and its possible mechanism in human erythroleukemia cells. Chin J Nat Med. 2020;18(10):749–59.

CAS  PubMed  Google Scholar 

Ganesan S, Mathews V, Vyas N. Microenvironment and drug resistance in acute myeloid leukemia: do we know enough? Int J Cancer. 2022;150(9):1401–11.

Article  CAS  PubMed  Google Scholar 

Huang X, Xiao F, Li Y, et al. Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia. J Exp Clin Cancer Res. 2018;37(1):310.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weiming Huang FC, Bian Yuting, Zhang Ruizeng, et al. Chemical constituents from Chloranthus multistachys and their anti-inflammatory activity. Nat Product Res Dev. 2020;32(10):1688–97.

Google Scholar 

Yang X. Bioactive material basis of medicinal plants in genus Chloranthus. Mod Chin Med. 2017;19(04):459–95.

Google Scholar 

Xu JB, Yu J, Zhang WQ, et al. Constituents from Chloranthus multistachys and their cytotoxic activities against various human cancer cell lines. J Asian Nat Prod Res. 2023;25(4):330–41.

Article  CAS  PubMed  Google Scholar 

Rose M, Burgess JT, O’Byrne K, et al. PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front Cell Dev Biol. 2020;8: 564601.

Article  PubMed  PubMed Central  Google Scholar 

Meyer-Ficca ML, Meyer RG, Jacobson EL, et al. Poly(ADP-ribose) polymerases: managing genome stability. Int J Biochem Cell Biol. 2005;37(5):920–6.

Article  CAS  PubMed  Google Scholar 

Csizmar CM, Saliba AN, Swisher EM, et al. PARP inhibitors and myeloid neoplasms: a double-edged sword. Cancers (Basel). 2021;13(24):6385.

Article  CAS  PubMed  Google Scholar 

Kontandreopoulou CN, Diamantopoulos PT, Tiblalexi D, et al. PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. Blood Adv. 2021;5(22):4794–805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gil-Kulik P, Dudzińska E, Radzikowska-Büchner E, et al. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells. BMC Cancer. 2020;20(1):435.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Padella A, Rorà Ghelli Luserna Di, A, Marconi G, et al. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. J Hematol Oncol. 2022;15(1):10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nemkov T, D’Alessandro A, Reisz JA. Metabolic underpinnings of leukemia pathology and treatment. Cancer Rep (Hoboken). 2019;2(2): e1139.

Article  PubMed  Google Scholar 

Gale RP. Can Immune therapy cure acute myeloid leukemia? Curr Treat Options Oncol. 2023;24(5):381–6.

Article  PubMed  PubMed Central  Google Scholar 

Maleknia M, Valizadeh A, Pezeshki SMS, Saki N. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties. Clin Transl Oncol. 2020;22(1):1–10.

Article  CAS  PubMed  Google Scholar 

Karantanou C, Godavarthy PS, Krause DS. Targeting the bone marrow microenvironment in acute leukemia. Leuk Lymphoma. 2018;59(11):2535–45.

Article  PubMed  Google Scholar 

Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8(4):603–19.

Article  CAS  PubMed  Google Scholar 

Kaloni D, Diepstraten ST, Strasser A, et al. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1–2):20–38.

Article  CAS  PubMed  Google Scholar 

Bah N, Maillet L, Ryan J, et al. Bcl-xL controls a switch between cell death modes during mitotic arrest. Cell Death Dis. 2014;5(6): e1291.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beyfuss K, Hood DA. A systematic review of p53 regulation of oxidative stress in skeletal muscle. Redox Rep. 2018;23(1):100–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teyssonneau D, Margot H, Cabart M, et al. Prostate cancer and PARP inhibitors: progress and challenges. J Hematol Oncol. 2021;14(1):51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cortesi L, Rugo HS, Jackisch C. An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol. 2021;16(3):255–82.

Article  PubMed  PubMed Central  Google Scholar 

Risdon EN, Chau CH, Price DK, et al. PARP inhibitors and prostate cancer: to infinity and beyond BRCA. Oncologist. 2021;26(1):e115–29.

Article  CAS  PubMed  Google Scholar 

Slade D. Mitotic functions of poly(ADP-ribose) polymerases. Biochem Pharmacol. 2019;167:33–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Engbrecht M, Mangerich A. The nucleolus and PARP1 in cancer biology. Cancers (Basel). 2020;12(7):1813.

Article  CAS  PubMed